Momelotinib is a benzamide obtained by formal condensation of the carboxy group of 4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzoic acid with the primary amino group of aminoacetonitrile. It is grouped under the following drug class(es): Antineoplastic agents, JAK inhibitors, Kinase inhibitors and Tyrosine Kinase Inhibitors. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ojjaara and CYT387. Its PubChem CID is 25062766.
Momelotinib
| CAS No | 1056634-68-4 |
|---|---|
| Molecular Formula | C23H22N6O2 |
| Molecular Weight | 414.50 g/mol |
| Synonyms | N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Momelotinib is a benzamide obtained by formal condensation of the carboxy group of 4-{2-[4-(morpholin-4-yl)anilino]pyrimidin-4-yl}benzoic acid with the primary amino group of aminoacetonitrile.
The listed CAS number is 1056634-68-4.
The listed molecular formula is C23H22N6O2.
The listed molecular weight is 414.50 g/mol.
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide.
The source lists Ojjaara and CYT387.